Therapeutic ethanol injection into primitive or secondary hepatic tumours if performed in 'one shot' causes a great deal of pain. For this reason an analgesic/sedation protocol was devised. This relies on the administration of ketorolac-propofol-nitrogen oxide mixture that has been used to treat patients with neoplastic hepatic diseases. A 20 patient series is described. Analgesic protocol was very effective and the only drawbacks were a residual sleepiness than in part is probably dependent on ethanol emigration into the bloodstream and consequently to the central nervous system depression.
Transcutaneous ethanol injection in hepatocarcinoma: Problems in analgesia and sedation / Iannarone, C., Caratozzolo, M., L., C., Fegiz, A., Tellan, G., I., B., A. M. R., M., A., F.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - STAMPA. - 1:6(1997), pp. 217-221.
Transcutaneous ethanol injection in hepatocarcinoma: Problems in analgesia and sedation
IANNARONE, Claudio;CARATOZZOLO, Marcello;FEGIZ, Alessandra;TELLAN, Guglielmo;
1997
Abstract
Therapeutic ethanol injection into primitive or secondary hepatic tumours if performed in 'one shot' causes a great deal of pain. For this reason an analgesic/sedation protocol was devised. This relies on the administration of ketorolac-propofol-nitrogen oxide mixture that has been used to treat patients with neoplastic hepatic diseases. A 20 patient series is described. Analgesic protocol was very effective and the only drawbacks were a residual sleepiness than in part is probably dependent on ethanol emigration into the bloodstream and consequently to the central nervous system depression.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
